Is Ivermectin safe during pregnancy?

Pregnancy is a sensitive period when every medication needs careful consideration. Medicines that are generally considered safe for adults may have different effects during pregnancy because a developing baby can be more vulnerable to certain substances. One medication that often raises questions is Ivermectin, an antiparasitic medicine used to treat infections caused by specific parasites.  Understanding whether this medication is appropriate during pregnancy requires looking at its purpose, possible side effects, available research, and potential risks to the developing baby. Although it is an effective treatment for certain parasitic infections, its safety during pregnancy has not been established with enough certainty to recommend routine use.

Ivermectin deserves particular attention because information from animal studies and limited human pregnancy data does not provide a complete picture of its effects on fetal development. Therefore, pregnant women should not take it without first consulting a qualified healthcare professional.

This guide explains what is currently known, why medical professionals exercise caution, what alternatives may be considered, and what pregnant women should do if they have already taken the medication.

What Is Ivermectin?

Ivermectin is an antiparasitic medication used to treat several infections caused by parasitic organisms. It works by interfering with the nervous system and muscle function of certain parasites, eventually causing paralysis and death.

It has been prescribed for conditions such as:

• Strongyloidiasis, an intestinal infection caused by parasitic worms.

• Onchocerciasis, also known as river blindness.

• Scabies, a skin infestation caused by microscopic mites.

• Certain other parasitic infections, depending on medical guidance and local treatment recommendations.

The medication is available in different formulations, including oral tablets and topical preparations. The appropriate formulation depends on the condition being treated.

It is important to understand that different formulations and doses are not automatically interchangeable. A medicine intended for animals should never be used by humans.

Is Ivermectin Safe During Pregnancy?

The safety of this medication during pregnancy has not been firmly established. Available human research is limited, and there is insufficient evidence to confirm that exposure does not increase the risk of pregnancy complications or harm to a developing baby.

For this reason, healthcare professionals generally recommend avoiding unnecessary exposure during pregnancy.

However, this does not mean that taking the medication will automatically cause harm. It means that the available evidence is not strong enough to establish its safety in every stage of pregnancy.

The decision should depend on several factors, including:

• The type of parasitic infection.

• The severity of the mother's symptoms.

• The stage of pregnancy.

• The potential consequences of leaving the infection untreated.

• The availability of alternative treatments.

• The mother's overall health.

A healthcare professional can evaluate these factors and determine the safest approach.

Why Is There Concern About Using This Medication During Pregnancy?

There are several reasons why doctors approach this medication cautiously when treating pregnant women.

1. Limited Human Research

One of the biggest concerns is the limited amount of reliable research involving pregnant women.

Clinical studies involving pregnant women are difficult to conduct because researchers must protect both the mother and developing baby. As a result, much of the available information comes from observational studies, accidental exposures, and animal research.

A systematic review published in 2020 examined the available evidence on oral treatment during pregnancy. It concluded that the available information was insufficient to establish a reliable safety profile.

This means researchers cannot confidently rule out every possible pregnancy-related risk.

2. Findings From Animal Studies

Animal studies have raised additional concerns.

Research involving mice, rats, and rabbits found developmental abnormalities when pregnant animals received repeated doses of the medication.

Reported abnormalities included:

• Cleft palate.

• Abnormal development of the forelimbs.

• Other developmental changes in certain experimental conditions.

These effects occurred at doses associated with toxicity in the pregnant animals.

It is important to understand that animal findings do not automatically predict what will happen in human pregnancies. Differences in metabolism, dosage, and biological development can affect how medicines behave across species.

Nevertheless, these findings are one reason why manufacturers and healthcare professionals recommend caution.

3. Uncertainty About Fetal Development

During pregnancy, the developing baby goes through several important stages.

Early pregnancy involves the development of major organs and body structures. Later stages involve continued growth and maturation of different systems.

Because researchers do not have enough high-quality human evidence, they cannot establish whether exposure at a particular stage carries a specific level of risk.

This uncertainty makes professional medical assessment especially important.

What Does Research Say About Ivermectin Exposure During Pregnancy?

Research into pregnancy exposure has produced some reassuring observations, but it has not established that the medication is completely safe.

Human Observational Studies

Some studies have examined women who accidentally received treatment during community-wide parasite control campaigns.

The available observations have not consistently demonstrated an increased rate of congenital abnormalities among exposed pregnancies.

The CDC acknowledges that available evidence has not shown a clear difference in congenital abnormalities between accidentally exposed women and women who were not exposed.

However, the CDC also explains that the evidence remains limited and recommends balancing the possible fetal risks against the consequences of untreated infection.

A Systematic Review of Pregnancy Safety

A systematic review and meta-analysis published in 2020 examined evidence concerning pregnancy outcomes after exposure.

The researchers considered outcomes such as miscarriage, stillbirth, and congenital abnormalities.

Although some findings were reassuring, the number and quality of available studies were not sufficient to establish safety.

This distinction is important. A study that does not identify a statistically significant increase in complications does not necessarily prove that no risk exists.

More research involving larger groups of pregnant women is needed.

Newer Research on Accidental Early Exposure

A study published in 2026 examined accidental exposure around conception and during the first four weeks of pregnancy.

It included 238 pregnant participants in Mozambique and Kenya. Researchers compared outcomes among women potentially exposed to the medication with outcomes among women exposed to albendazole.

The study did not identify a statistically significant difference in adverse pregnancy outcomes between the treatment groups.

However, the researchers emphasized that the confidence intervals were broad and that the findings were not sufficient to establish a definitive safety conclusion.

This research adds useful information, but it does not change the need for caution.

Does Pregnancy Stage Affect the Risks?

The stage of pregnancy is an important consideration when evaluating medication exposure.

Different stages involve different developmental processes, so healthcare professionals consider the timing of exposure when assessing possible risks.

First Trimester

The first trimester covers approximately the first 12 weeks of pregnancy.

During this period, the embryo develops many of its major organs and structures. This makes medication exposure an important consideration.

Because available evidence is limited, pregnant women should avoid taking unnecessary medication during this stage.

If exposure has already occurred, a doctor can assess the timing, amount, and type of medication involved.

Second Trimester

The second trimester generally covers weeks 13 through 27.

During this stage, the baby's organs continue developing, and the body grows rapidly.

Some observational research has examined exposure during the second trimester. Although certain findings have been reassuring, they do not establish that treatment is risk-free.

A healthcare professional should determine whether the benefits of treating an infection outweigh possible risks.

Third Trimester

The third trimester begins around week 28 and continues until delivery.

The baby continues growing, gaining weight, and developing important body functions.

There is not enough evidence to establish a completely safe period for taking this medication during pregnancy.

Therefore, women should not assume that treatment becomes automatically safe during the later months.

What If a Pregnant Woman Accidentally Takes Ivermectin?

Accidental exposure can cause considerable anxiety, particularly when a woman discovers that she is pregnant after taking medication.

However, accidental exposure does not automatically mean that the baby will experience complications.

The available human evidence has not established that every exposure causes fetal harm.

The most important step is to obtain appropriate medical advice rather than panic or make assumptions.

Steps to Take After Accidental Exposure

If you have taken the medication while pregnant or before realizing you were pregnant, consider the following steps:

1. Stop taking additional doses until advised.

Do not take another dose without discussing the situation with your healthcare professional.

2. Contact your doctor.

Inform your obstetrician, general practitioner, or pharmacist about the exposure.

3. Provide the medication details.

Share the following information:

• Name of the medication.

• Amount taken.

• Date and time of exposure.

• Number of doses.

• Whether it was an oral or topical formulation.

• Approximate stage of pregnancy.

4. Follow recommended pregnancy monitoring.

Your healthcare professional may recommend routine prenatal appointments or additional assessments depending on your circumstances.

5. Avoid unnecessary online treatments.

Do not attempt to counteract the medication using supplements, herbal products, or other medicines.

There is no reason to assume that an isolated accidental exposure will automatically result in a pregnancy complication.

Are Oral and Topical Formulations Equally Concerning?

The formulation matters because different preparations produce different levels of exposure throughout the body.

Oral Tablets

Oral tablets are absorbed through the digestive system and enter the bloodstream.

This creates systemic exposure, meaning the medication can circulate throughout the body.

The prescribing information for oral treatment states that adequate and well-controlled studies in pregnant women are unavailable and that the medication should not be used during pregnancy because its safety has not been established.

Topical Creams

Topical preparations are applied directly to the skin.

Depending on the product, formulation, application area, and skin condition, less medication may enter the bloodstream compared with oral treatment.

However, lower systemic absorption does not mean zero exposure.

The prescribing information for topical preparations also states that available pregnancy data are insufficient to establish whether treatment increases the risk of birth defects, miscarriage, or other adverse outcomes.

A doctor should evaluate whether a topical preparation is appropriate during pregnancy rather than assuming that skin application makes it completely safe.

What Are the Risks of Leaving a Parasitic Infection Untreated?

Avoiding unnecessary medication is important during pregnancy, but ignoring an infection can also create health problems.

Certain parasitic infections may cause significant illness, nutritional difficulties, digestive problems, or complications related to the mother's general health.

The risks depend on the parasite, the severity of the infection, and the woman's medical condition.

Strongyloidiasis

Strongyloidiasis is an infection caused by a parasitic worm called Strongyloides stercoralis.

Some people experience mild symptoms, while others may develop serious complications.

People with weakened immune systems can be particularly vulnerable to severe disease.

A healthcare professional should assess the infection and determine whether treatment can safely be delayed or whether another approach is necessary.

Onchocerciasis

Onchocerciasis is a parasitic disease that can affect the skin and eyes.

Infection can cause persistent itching, skin changes, and vision problems.

Because untreated disease may have long-term consequences, treatment decisions should consider both maternal health and fetal safety.

Scabies

Scabies is caused by microscopic mites that burrow into the skin.

Common symptoms include intense itching, irritation, and small skin rashes.

Although scabies is usually not a life-threatening infection, it can cause considerable discomfort and spread through close personal contact.

Pregnant women should seek medical advice about appropriate treatment rather than using an oral or topical medication without professional guidance.

What Treatment Options May Be Available During Pregnancy?

Treatment depends on the specific infection. There is no single alternative that is suitable for every parasitic condition.

A healthcare professional may consider other medications or non-medication approaches depending on the diagnosis and pregnancy stage.

Alternative Medicines for Scabies

For pregnant women with scabies, a doctor may consider alternative treatments with more established pregnancy guidance.

Permethrin 5% cream is commonly used to treat scabies and is generally considered an option during pregnancy when clinically appropriate.

It is applied according to medical instructions, usually over the affected areas of the skin.

The correct application method and treatment schedule are important because incomplete treatment can allow the infestation to continue.

Treatment for Intestinal Parasites

Some intestinal parasitic infections may be treated with other medications, depending on the type of parasite.

For example, healthcare professionals may consider certain treatments involving albendazole or mebendazole in specific circumstances.

However, these medicines also have pregnancy-related precautions. Their suitability depends on the stage of pregnancy, the infection being treated, and the potential benefits and risks.

Do not replace one medication with another without medical advice.

Non-Medication Measures

Supportive measures can help reduce discomfort and prevent certain infections from spreading.

Depending on the condition, these measures may include:

• Maintaining good personal hygiene.

• Washing hands regularly.

• Keeping fingernails clean and trimmed.

• Washing clothing and bedding when recommended.

• Avoiding close contact with infected individuals when appropriate.

• Following proper food preparation and sanitation practices.

These measures are useful for prevention and infection control, but they do not replace necessary medical treatment.

Who Should Be Consulted Before Taking Ivermectin?

Pregnant women should consult a qualified healthcare professional before using any prescription medication.

Several medical professionals may contribute to the decision.

Obstetrician or Gynecologist

An obstetrician understands pregnancy-related health concerns and can evaluate the possible effects of medication exposure on the mother and baby.

They can also recommend appropriate pregnancy monitoring when necessary.

Infectious Disease Specialist

If the woman has a serious or complicated parasitic infection, an infectious disease specialist may help identify the most appropriate treatment.

This is particularly important when delaying treatment could create significant health risks.

Pharmacist

A pharmacist can review the medication formulation, dosage instructions, potential interactions, and pregnancy warnings.

They can also help identify whether a product is intended for human use.

A pharmacist's advice should complement, rather than replace, an appropriate medical assessment.

Important Precautions for Pregnant Women

Taking precautions can reduce the likelihood of unnecessary medication exposure.

Consider the following recommendations:

Avoid self-medication: Never start treatment based on online recommendations or another person's prescription.

Check medication labels: Read the pregnancy warnings and confirm that the product is intended for human use.

Disclose your pregnancy: Inform doctors and pharmacists if you are pregnant, planning pregnancy, or think you may be pregnant.

Discuss existing medicines: Provide a complete list of prescription medicines, over-the-counter products, and supplements you use.

Do not change prescribed treatment independently: If you have an infection, speak with your doctor before stopping or changing an existing treatment plan.

Avoid veterinary products: Animal formulations may contain different concentrations and ingredients and are not appropriate substitutes for human medication.

These precautions are especially important when purchasing medication without a prescription or obtaining treatment through online sources.

Can Ivermectin Affect Fertility or Future Pregnancy?

Questions about fertility often arise when women are planning to become pregnant.

Current evidence does not establish that ordinary human therapeutic exposure causes infertility.

Animal fertility studies reported no adverse effects on fertility in rats at the tested doses described in the prescribing information.

However, these findings cannot establish every aspect of reproductive safety in humans.

Women planning pregnancy should discuss treatment timing with their healthcare professional, especially if they have a diagnosed parasitic infection.

The doctor can consider the expected treatment duration, the possibility of pregnancy, and whether delaying conception or selecting another treatment would be appropriate.

There is also no universally established waiting period after treatment that applies to every patient. Individual circumstances and the specific product should guide medical advice.

Conclusion

The question of whether Ivermectin is safe during pregnancy requires careful consideration. Although this medication is effective against several parasitic infections, its safety during pregnancy has not been established through sufficient high-quality human research.

Animal studies have identified developmental abnormalities at certain doses, while observational studies involving pregnant women have produced some reassuring findings. However, these findings are not strong enough to confirm that the medication is completely safe for an unborn baby.

For this reason, routine use during pregnancy should be avoided unless a qualified healthcare professional determines that the potential benefits outweigh the possible risks.

Pregnant women should never start treatment independently, whether they are considering oral tablets or topical preparations. If a parasitic infection is diagnosed, the doctor should evaluate its severity, the stage of pregnancy, and the availability of alternative treatments.

Women who accidentally take the medication before discovering their pregnancy should not assume that their baby has been harmed. They should contact their healthcare professional, provide accurate information about the exposure, and follow recommended prenatal care.

Ultimately, protecting maternal health and supporting healthy fetal development require informed medical decisions. The safest approach is to avoid unnecessary medication, treat infections appropriately, and seek professional guidance whenever questions about medication safety arise.